title: Reply: Comment on 'Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'--β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs.
authors: 1] Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Randwick, NSW 2031, Australia [2] Metronomics Global Health Initiative, Marseille 13005, France.
authors: E
authors: E
authors: Pasquier
authors: N
authors: N
authors: Andre
authors: T
authors: T
authors: Trahair
authors: M
authors: M
authors: Kavallaris
mesh_terms: D000008:Abdominal Neoplasms / Q000188:drug therapy*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D009447:Neuroblastoma / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D020533:Angiogenesis Inhibitors
references: Lancet Oncol. 2013 May;14(6):e239-48
references: 23639324
references: J Clin Oncol. 2008 Mar 20;26(9):1504-10
references: 18349403
references: Arch Intern Med. 2011 Apr 25;171(8):779-81
references: 21518948
references: J Clin Oncol. 2011 Jul 1;29(19):2635-44
references: 21632503
references: Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2273-9
references: 21933972
references: N Engl J Med. 2008 Jun 12;358(24):2649-51
references: 18550886
references: Oncotarget. 2010 Nov;1(7):628-38
references: 21317458
references: Ann Oncol. 2013 May;24(5):1312-9
references: 23300016
references: Oncotarget. 2011 Oct;2(10):797-809
references: 22006582
references: Gynecol Oncol. 2012 Nov;127(2):375-8
references: 22819786
references: J Clin Oncol. 2011 Feb 1;29(4):449-55
references: 21172879
references: J Clin Oncol. 2011 Jul 1;29(19):2645-52
references: 21632501
references: N Engl J Med. 2010 Sep 30;363(14):1313-23
references: 20879880
references: J Clin Oncol. 2012 May 20;30(15):1842-8
references: 22529259
references: Br J Cancer. 2013 Oct 1;109(7):2022-3
references: 23969727
references: J Clin Oncol. 2009 Mar 1;27(7):1026-33
references: 19171713
references: Br J Cancer. 2013 Jun 25;108(12):2485-94
references: 23695022
references: J Clin Oncol. 2009 Mar 1;27(7):1034-40
references: 19171711